Cue Biopharma, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cue Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Cue Biopharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$10.4M, a 23.2% increase year-over-year.
  • Cue Biopharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$48.3M, a 8.51% increase year-over-year.
  • Cue Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$52.1M, a 2.02% increase from 2022.
  • Cue Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$53.2M, a 21.8% decline from 2021.
  • Cue Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$43.7M, a 2.95% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$52.1M +$1.08M +2.02% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$53.2M -$9.51M -21.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$43.7M +$1.33M +2.95% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 -$45M -$8.27M -22.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 -$36.8M +$1.93M +4.98% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 -$38.7M -$15.5M -66.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$23.2M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.